About Us

At the heart of getting medicines to those who need them.

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 19,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference.

With Heart

 

Our Values

Patients first

Patients first

Each of us, no matter what we do at Parexel, contributes to the development of a therapy that ultimately will benefit a patient. We take our work personally, we do it with empathy and we're committed to making a difference.

Quality

Quality

From the smallest detail to the largest, we take quality seriously. We focus in on the detail while never losing sight of the big picture to drive the best possible outcome.

Respect

Respect

We recognize and uphold the importance of all people, the way we do things, our quest for innovation and most importantly, our patients.

Empowerment and accountability

Empowerment and accountability

We follow our hearts, we do the right thing and we have the courage to own the outcome.

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference